These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22913897)

  • 1. Diabetes pharmacotherapy in 2012: considerations in medication selection.
    Cornell S; Dorsey VJ
    Postgrad Med; 2012 Jul; 124(4):84-94. PubMed ID: 22913897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challenges.
    Gavin JR; Stolar MW; Freeman JS; Spellman CW
    J Am Osteopath Assoc; 2010 May; 110(5 Suppl 6):S2-14; quiz S15-6. PubMed ID: 20554501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating treatment algorithms for the management of patients with type 2 diabetes mellitus: a perspective on the definition of treatment success.
    Aguilar RB
    Clin Ther; 2011 Apr; 33(4):408-24. PubMed ID: 21635988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical practice in type 2 diabetes: After metformin and lifestyle, then what?
    Cobble ME; Peters AL
    J Fam Pract; 2009 Nov; 58(11 Suppl Clinical):S7-14. PubMed ID: 19891948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key considerations in pharmacotherapy for type 2 diabetes mellitus: a multiple target organ approach.
    Cornell S
    J Clin Pharm Ther; 2012 Jun; 37(3):254-9. PubMed ID: 21955063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals.
    Lavernia F; Adkins SE; Shubrook JH
    Postgrad Med; 2015; 127(8):808-17. PubMed ID: 26439384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical Management of the Diabetic Patient.
    Clement S
    Clin Podiatr Med Surg; 2019 Jul; 36(3):349-354. PubMed ID: 31079601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of glycemic control and variability in patients with type 2 and posttransplantation diabetes mellitus.
    Werzowa J; Pacini G; Hecking M; Fidler C; Haidinger M; Brath H; Thomas A; Säemann MD; Tura A
    J Diabetes Complications; 2015; 29(8):1211-6. PubMed ID: 26264400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of current and emerging therapies in type 2 diabetes mellitus.
    Mazzola N
    Am J Manag Care; 2012 Jan; 18(1 Suppl):S17-26. PubMed ID: 22559854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of linagliptin in subjects with long-standing type 2 diabetes mellitus (>10 years): evidence from pooled data of randomized, double-blind, placebo-controlled, phase III trials.
    Lajara R; Aguilar R; Hehnke U; Woerle HJ; von Eynatten M
    Clin Ther; 2014 Nov; 36(11):1595-605. PubMed ID: 25236917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.
    Rodbard HW; Jellinger PS; Davidson JA; Einhorn D; Garber AJ; Grunberger G; Handelsman Y; Horton ES; Lebovitz H; Levy P; Moghissi ES; Schwartz SS
    Endocr Pract; 2009; 15(6):540-59. PubMed ID: 19858063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Real-World Observational Study of Time to Treatment Intensification Among Elderly Patients with Inadequately Controlled Type 2 Diabetes Mellitus.
    Ajmera M; Raval A; Zhou S; Wei W; Bhattacharya R; Pan C; Sambamoorthi U
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1184-93. PubMed ID: 26679967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agents for the treatment of diabetes mellitus.
    O'Mara NB
    Semin Dial; 2010; 23(5):475-9. PubMed ID: 21069919
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral antidiabetic drug therapy in type 2 diabetes mellitus - focus on elderly patients.
    Lechleitner M
    Wien Med Wochenschr; 2011 Jun; 161(11-12):297-9. PubMed ID: 21769711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of diabetes patients attending a hospital diabetes clinic.
    Siu SC; Lo SK; Wong KW
    Diabetes Res Clin Pract; 2004 Apr; 64(1):73-4. PubMed ID: 15036830
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diabetes in old age--risk by over- and undertreatment].
    Zeyfang A; Bahrmann A
    MMW Fortschr Med; 2013 Jul; 155(13):56-8. PubMed ID: 23964510
    [No Abstract]   [Full Text] [Related]  

  • 18. [GLycemic control in the diabetic patient. Recommendations after the DCCT and UKPDI studies].
    Paquot N; Scheen AJ; Lefèbvre PJ
    Rev Med Liege; 2000 May; 55(5):372-5. PubMed ID: 10941300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult.
    Thompson AM; Linnebur SA; Vande Griend JP; Saseen JJ
    Consult Pharm; 2014 Feb; 29(2):110-23. PubMed ID: 24513421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidimensional pharmacologic strategies for diabetes.
    Edmisson KW
    Nurs Clin North Am; 2005 Mar; 40(1):107-17. PubMed ID: 15733950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.